Our Favorite Biotech Trade
Over the past 12 months, biotech’s been booming:
In fact, the NASDAQ Biotechnology Index (NBI) has risen by more than 46%.
IPOs have played a big part in that rise...
For example, Ultragenyx Pharmaceutical (NASDAQ: RARE), debuted at $21 and now sits at over $60 per share. That’s a 300%…